Voloridge Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $224K | Sell |
|
|||||
|
2024
Q2 | $336K | Sell |
|
|||||
|
2024
Q1 | $2.78M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $3.97M | Sell |
|
|||||
|
2023
Q1 | $8.32M | Buy |
|
|||||
|
2022
Q4 | $5.36M | Buy |
|
|||||
|
2022
Q3 | $11.7M | Buy |
|
|||||
|
2022
Q2 | $11.8M | Buy |
|
|||||
|
2022
Q1 | $8.48M | Sell |
|
|||||
|
2021
Q4 | $15.8M | Buy |
|
|||||
|
2021
Q3 | $7.38M | Buy |
|
|||||
|
2021
Q2 | $876K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $3.2M | Buy |
|
|||||
|
2020
Q3 | $1.12M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $759K | Buy |
|